Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of ORCHID PHARMA. For more details, see the ORCHID PHARMA quarterly results and ORCHID PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.1 |
No. of shares | m | 50.72 |
1 Week | % | -2.7 |
1 Month | % | 1.2 |
1 Year | % | 180.1 |
52 week H/L | Rs | 1,358.8/371.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ORCHID PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 14 | 8 | 2,465 | 2,680 | 439 | |
Low | Rs | 3 | 4 | 18 | 260 | 273 | |
Sales per share (Unadj.) | Rs | 67.4 | 118.5 | 110.3 | 137.1 | 163.1 | |
Earnings per share (Unadj.) | Rs | 7.8 | -17.1 | -23.3 | -13.9 | 13.5 | |
Diluted earnings per share | Rs | 13.7 | -13.7 | -18.8 | -11.2 | 10.9 | |
Cash flow per share (Unadj.) | Rs | 22.4 | 11.8 | 3.3 | 7.4 | 27.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | -79.1 | 187.6 | 159.9 | 158.6 | 168.7 | |
Adj. book value per share | Rs | -138.8 | 151.0 | 128.7 | 127.6 | 135.8 | |
Shares outstanding (eoy) | m | 88.96 | 40.82 | 40.82 | 40.82 | 40.82 | |
Price / Sales ratio | x | 0.1 | 0.1 | 11.3 | 10.7 | 2.2 | |
Avg P/E ratio | x | 1.1 | -0.4 | -53.2 | -105.5 | 26.3 | |
P/CF ratio (eoy) | x | 0.4 | 0.5 | 370.8 | 199.2 | 13.2 | |
Price / Book Value ratio | x | -0.1 | 0 | 7.8 | 9.3 | 2.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 742 | 249 | 50,677 | 60,004 | 14,522 | |
Total wages/salary | Rs m | 823 | 749 | 671 | 633 | 654 |
ORCHID PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6,000 | 4,838 | 4,501 | 5,596 | 6,659 | |
Other income | Rs m | 169 | 243 | 152 | 90 | 194 | |
Total revenues | Rs m | 6,169 | 5,081 | 4,653 | 5,686 | 6,853 | |
Gross profit | Rs m | 1,891 | 302 | 507 | 546 | 1,235 | |
Depreciation | Rs m | 1,299 | 1,179 | 1,089 | 870 | 548 | |
Interest | Rs m | 67 | 62 | 522 | 335 | 329 | |
Profit before tax | Rs m | 694 | -697 | -952 | -569 | 552 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 694 | -697 | -952 | -569 | 552 | |
Gross profit margin | % | 31.5 | 6.2 | 11.3 | 9.8 | 18.5 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | 11.6 | -14.4 | -21.2 | -10.2 | 8.3 |
ORCHID PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 7,675 | 5,693 | 4,290 | 3,844 | 5,010 | |
Current liabilities | Rs m | 23,455 | 1,749 | 1,421 | 2,408 | 3,719 | |
Net working cap to sales | % | -263.0 | 81.5 | 63.8 | 25.7 | 19.4 | |
Current ratio | x | 0.3 | 3.3 | 3.0 | 1.6 | 1.3 | |
Inventory Days | Days | 472 | 5 | 20 | 78 | 57 | |
Debtors Days | Days | 729 | 513 | 1,101 | 1,113 | 1,180 | |
Net fixed assets | Rs m | 23,096 | 8,906 | 6,874 | 7,129 | 7,242 | |
Share capital | Rs m | 890 | 408 | 408 | 408 | 408 | |
"Free" reserves | Rs m | -7,930 | 7,252 | 6,121 | 6,066 | 6,478 | |
Net worth | Rs m | -7,040 | 7,660 | 6,529 | 6,474 | 6,886 | |
Long term debt | Rs m | 14,246 | 5,040 | 4,275 | 2,082 | 1,488 | |
Total assets | Rs m | 30,770 | 14,599 | 12,373 | 11,106 | 12,252 | |
Interest coverage | x | 11.4 | -10.2 | -0.8 | -0.7 | 2.7 | |
Debt to equity ratio | x | -2.0 | 0.7 | 0.7 | 0.3 | 0.2 | |
Sales to assets ratio | x | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | |
Return on assets | % | 2.5 | -4.3 | -3.5 | -2.1 | 7.2 | |
Return on equity | % | -9.9 | -9.1 | -14.6 | -8.8 | 8.0 | |
Return on capital | % | 10.6 | -5.0 | -4.0 | -2.7 | 10.5 | |
Exports to sales | % | 80.0 | 91.3 | 88.1 | 86.3 | 81.9 | |
Imports to sales | % | 28.1 | 31.3 | 37.3 | 34.9 | 37.6 | |
Exports (fob) | Rs m | 4,798 | 4,416 | 3,966 | 4,830 | 5,452 | |
Imports (cif) | Rs m | 1,688 | 1,514 | 1,677 | 1,951 | 2,501 | |
Fx inflow | Rs m | 4,798 | 4,416 | 3,966 | 4,830 | 5,452 | |
Fx outflow | Rs m | 1,864 | 1,605 | 1,729 | 2,049 | 2,726 | |
Net fx | Rs m | 2,934 | 2,810 | 2,237 | 2,781 | 2,726 |
ORCHID PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 120 | 808 | 236 | 925 | 183 | |
From Investments | Rs m | 455 | 1,671 | 672 | 1,129 | -312 | |
From Financial Activity | Rs m | -3 | -2,503 | -1,650 | -2,168 | 312 | |
Net Cashflow | Rs m | 572 | -24 | -742 | -114 | 183 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Ram Gopal Agarwal | COMP SEC: Kapil Dayya | YEAR OF INC: 1992 | BSE CODE: 524372 | FV (Rs): 10 | DIV YIELD (%): - |
Read: ORCHID PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare ORCHID PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.